If they were to change the patient size to 130, as they have suggested, how long do you think it will take for the EMA to approve it, and do you think they could remove PMD as a secondary measure also?
Ann: Phase III Clinical Trial Update and New IIH Market Analysis, page-156
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.335M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 532 | 7.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.5¢ | 8695 | 1 |
View Market Depth
| Last trade - 16.12pm 09/08/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable